Product Code: ETC4470876 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 |
The neurostimulation market in Australia is growing as AI-driven medical devices enhance the treatment of neurological disorders such as chronic pain, epilepsy, and Parkinsons disease. Innovations in spinal cord stimulators, deep brain stimulators, and non-invasive neuromodulation therapies are improving patient outcomes and expanding the market.
The neurostimulation market in Australia is expanding due to increasing cases of neurological disorders such as chronic pain, epilepsy, and Parkinson`s disease. Rising adoption of deep brain stimulation, spinal cord stimulation, and vagus nerve stimulation for managing chronic pain and movement disorders is driving market growth. Enhanced focus on improving device precision, battery life, and patient outcomes is supporting market performance.
The neurostimulation market in Australia faces challenges from high costs of neurostimulation devices and stringent regulatory approvals. Limited awareness among healthcare providers and patient resistance to invasive treatments further restrict market adoption.
The Australia Neurostimulation Market presents significant investment potential due to growing demand for chronic pain management and neurological treatments. Investment opportunities include developing AI-integrated neurostimulation devices, improving treatment precision, and expanding into mental health and rehabilitation sectors.
Neurostimulation devices used for pain management and neurological disorders are regulated under the Therapeutic Goods Act 1989. The government mandates that neurostimulation systems meet performance and safety standards set by the TGA.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Neurostimulation Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Neurostimulation Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Neurostimulation Market - Industry Life Cycle |
3.4 Australia Neurostimulation Market - Porter's Five Forces |
3.5 Australia Neurostimulation Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Neurostimulation Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Neurostimulation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Australia |
4.2.2 Technological advancements in neurostimulation devices |
4.2.3 Rising demand for minimally invasive procedures in healthcare |
4.3 Market Restraints |
4.3.1 High cost associated with neurostimulation therapies |
4.3.2 Stringent regulatory requirements for approval of neurostimulation devices |
4.3.3 Limited awareness and adoption of neurostimulation therapies among healthcare providers and patients |
5 Australia Neurostimulation Market Trends |
6 Australia Neurostimulation Market, By Types |
6.1 Australia Neurostimulation Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Neurostimulation Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Australia Neurostimulation Market Revenues & Volume, By Spinal Cord Stimulator, 2021-2031F |
6.1.4 Australia Neurostimulation Market Revenues & Volume, By Deep Brain Stimulator, 2021-2031F |
6.1.5 Australia Neurostimulation Market Revenues & Volume, By Sacral Nerve Stimulator, 2021-2031F |
6.1.6 Australia Neurostimulation Market Revenues & Volume, By Vagus Nerve Stimulator, 2021-2031F |
6.1.7 Australia Neurostimulation Market Revenues & Volume, By Gastric Electric Stimulator, 2021-2031F |
6.2 Australia Neurostimulation Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Neurostimulation Market Revenues & Volume, By Pain Management, 2021-2031F |
6.2.3 Australia Neurostimulation Market Revenues & Volume, By Epilepsy, 2021-2031F |
6.2.4 Australia Neurostimulation Market Revenues & Volume, By Essential Tremor, 2021-2031F |
6.2.5 Australia Neurostimulation Market Revenues & Volume, By Urinary and Fecal Incontinence, 2021-2031F |
6.2.6 Australia Neurostimulation Market Revenues & Volume, By Depression, 2021-2031F |
6.2.7 Australia Neurostimulation Market Revenues & Volume, By Dystonia, 2021-2031F |
7 Australia Neurostimulation Market Import-Export Trade Statistics |
7.1 Australia Neurostimulation Market Export to Major Countries |
7.2 Australia Neurostimulation Market Imports from Major Countries |
8 Australia Neurostimulation Market Key Performance Indicators |
8.1 Patient satisfaction rates post neurostimulation therapy |
8.2 Number of clinical trials and research studies conducted on neurostimulation in Australia |
8.3 Adoption rate of neurostimulation therapies among healthcare facilities in Australia |
9 Australia Neurostimulation Market - Opportunity Assessment |
9.1 Australia Neurostimulation Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Neurostimulation Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Neurostimulation Market - Competitive Landscape |
10.1 Australia Neurostimulation Market Revenue Share, By Companies, 2024 |
10.2 Australia Neurostimulation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |